A simple blood draw could spot prostate cancer early

NCT ID NCT04556916

Recruiting now Diagnosis Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates whether a blood test (liquid biopsy) can detect prostate cancer early by looking for tumor cells and genetic material in the blood. Researchers will compare blood samples from men with suspected prostate cancer to those without the disease. The goal is to find a reliable, non-invasive way to identify aggressive cancers and reduce unnecessary biopsies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Blood sample analysis for circulating tumor cells, DNA, and exosomes
What this could lead to: If successful, this could lead to a simple blood test that detects prostate cancer earlier and more accurately than current methods, potentially reducing unnecessary biopsies.
What could go wrong: This is an early-stage study with 320 participants, so the test may not prove accurate enough for widespread use. The results need validation in larger studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

CHU Montpellier - Département d'urologie et transplantation rénale
RECRUITING

Montpellier, France
CHU Montpellier - Laboratoire des Cellules Circulantes Rares Humaines
ACTIVE_NOT_RECRUITING

Montpellier, France
CHU de Nîmes - Service Urologie Andrologie Sexologie
RECRUITING

Nîmes, France
Clinique Beau Soleil - Service d'urologie
RECRUITING

Montpellier, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.